tiprankstipranks
Trending News
More News >

Hepion Pharmaceuticals Holds Annual Stockholders Meeting

Story Highlights
Hepion Pharmaceuticals Holds Annual Stockholders Meeting

Don’t Miss TipRanks’ Half-Year Sale

The latest announcement is out from Hepion Pharmaceuticals ( (HEPA) ).

On June 12, 2025, Hepion Pharmaceuticals held its Annual Meeting of Stockholders, where four key proposals were voted on. These included the election of directors, ratification of auditors, approval of a reverse stock split, and an advisory vote on executive compensation. The outcomes of these votes could impact the company’s governance and financial strategies, particularly the reverse stock split, which allows flexibility in managing stock value.

More about Hepion Pharmaceuticals

Hepion Pharmaceuticals, Inc. operates in the pharmaceutical industry, focusing on developing therapies for liver diseases. The company is engaged in the research and development of treatments targeting chronic liver conditions.

Average Trading Volume: 4,708,755

Technical Sentiment Signal: Strong Sell

Current Market Cap: $792.5K

For an in-depth examination of HEPA stock, go to TipRanks’ Overview page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1